Mexico Vaccines Market Overview, 2028

Mexico's vaccines market has undergone significant transformation in recent years, driven by various factors such as government initiatives, expanding immunization programs, and growing public awareness. This article delves into the current landscape of the Mexican vaccines market, exploring key trends, challenges, and initiatives that are shaping the nation's approach to vaccination. Mexico has a robust national immunization program that focuses on providing essential vaccines to its population. Led by the Secretariat of Health (Secretaría de Salud), these programs aim to ensure that all Mexicans, regardless of socio-economic status, have access to vital vaccines. The government's commitment to vaccination has played a pivotal role in boosting vaccine coverage rates. Over the years, Mexico has expanded its vaccine recommendations to include a broader range of vaccines for children and adults. This expansion reflects the nation's commitment to preventing a wide spectrum of vaccine-preventable diseases. It also aligns with global efforts to control outbreaks and enhance public health. To increase public awareness about the importance of vaccination, Mexico conducts vaccination awareness campaigns. These campaigns target both urban and rural communities, providing information about vaccination schedules, vaccine safety, and the benefits of immunization. The goal is to combat vaccine hesitancy and encourage timely vaccinations. Mexico actively engages in global health initiatives, including partnerships with international organizations like the World Health Organization (WHO) and UNICEF. The nation's involvement in these initiatives underscores its dedication to improving vaccine access and addressing global health challenges. According to the research report "Mexico Vaccines Market Overview, 2028," published by Bonafide Research, the Mexico Vaccines market is expected to reach market size of more than USD 1 Billion by 2028. Mexico has expanded its vaccine recommendations to cover a broader range of diseases and age groups. This expansion increases the demand for vaccines as it encourages more individuals to get vaccinated against various preventable diseases. The Mexican government has a number of programs in place to promote vaccination, such as the National Vaccination Program (PNV) and the Expanded Program on Immunization (EPI). These programs provide free vaccines to children and adults against a number of diseases, including measles, mumps, rubella, polio, and tetanus. The private healthcare sector in Mexico is also playing a role in driving the demand for vaccines. Many private healthcare providers offer vaccination services to their patients, and some even offer discounted vaccines. There has been a number of public awareness campaigns in Mexico aimed at increasing awareness of the importance of vaccination. These campaigns have been effective in educating the public about the benefits of vaccination and the risks of not vaccinating. Trust in vaccines and healthcare providers are a key driver of vaccine demand. Public trust in the safety and efficacy of vaccines and confidence in healthcare professionals encourage vaccination. Mexico has a growing population, including a significant proportion of young children and a growing elderly population. This demographic profile increases the demand for pediatric and adult vaccines, respectively. The private healthcare sector in Mexico also plays a role in driving vaccine demand. Many private healthcare providers offer vaccination services, increasing accessibility for those who prefer private healthcare.?

Based on the technology types includes the Conjugate Vaccines, Inactivated & Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines and Toxoid Vaccines. Recombinant Vaccines is growing market, Recombinant vaccines are known for their safety and efficacy. They are developed using biotechnology techniques that allow for precise targeting of specific antigens, reducing the risk of adverse reactions. This safety profile appeals to both healthcare providers and patients. Recombinant vaccines have been developed for a range of diseases, including hepatitis B and human papillomavirus (HPV). These vaccines offer highly effective protection against diseases that are prevalent in Mexico, driving demand for their use. Mexico's government has actively promoted the use of recombinant vaccines in its national immunization program. Initiatives to vaccinate against diseases like hepatitis B have contributed to the growth of this vaccine category. Recombinant vaccines are recognized as important tools in addressing global health priorities, such as preventing infectious diseases and reducing the burden on healthcare systems. Mexico's commitment to global health efforts aligns with the adoption of these vaccines. According to the report the end user segmented into the Pediatric Vaccines and Adult Vaccines, in Mexico the Pediatric Vaccines is leading market, Mexico has a robust national immunization program that focuses on providing vaccines to children free of charge or at subsidized rates. The government's commitment to pediatric immunization ensures wide accessibility to vaccines, driving demand. Vaccination is recognized as one of the most effective tools for preventing vaccine-preventable diseases in children. Parents and caregivers are increasingly aware of the benefits of vaccines in protecting their children from serious illnesses, which drives demand for pediatric vaccines. In many regions of Mexico, vaccination records are required for school entry. This policy encourages parents to ensure their children are up-to-date with their vaccinations to meet school enrollment requirements. Mexico is committed to global health priorities and follows international vaccination guidelines. This commitment to aligning with global efforts further promotes the growth of pediatric vaccination. Based on the route of administration, they are segmented into intramuscular and subcutaneous administration, oral administration, and others. In the country where the Oral Administration is growing, Mexico has historically conducted extensive oral polio vaccine (OPV) campaigns as part of global efforts to eradicate polio. These campaigns involve the oral administration of the vaccine, making it an important method for reaching a large population. Some diseases, such as rotavirus, enter the body through the gastrointestinal tract. Oral vaccines can stimulate mucosal immunity in addition to systemic immunity, which can be more effective in preventing diseases that affect the mucous membranes. Rotavirus vaccines, for example, are administered orally in Mexico to protect against severe diarrhoea in infants. Mexico has implemented various public health initiatives to increase vaccination rates, including the use of oral vaccines. These initiatives may target specific diseases or age groups and can contribute to the growth of oral vaccine administration. Some oral vaccines are more stable at higher temperatures compared to their injectable counterparts. This can be advantageous in regions with limited access to reliable refrigeration. In terms of disease types, they include the rotavirus, pneumococcal diseases, cancer, influenza, diphtheria, pertussis, and tetanus, the human papilloma virus (HPV), hepatitis, shingles, meningococcal diseases, varicella, mumps, and others. Rotavirus is a leading cause of severe diarrhea in infants and young children worldwide, including in Mexico. The disease can lead to hospitalisations and even fatalities in severe cases. To address this significant public health concern, Mexico introduced the rotavirus vaccine to reduce the burden of rotavirus-related illnesses. Mexico, like many other countries, has implemented public health initiatives to increase rotavirus vaccine coverage. These initiatives aimed to ensure that a large proportion of infants and young children received the recommended doses of the vaccine. The rotavirus vaccine has been shown to be highly effective in preventing severe rotavirus gastroenteritis. This effectiveness contributes to its acceptance and use in vaccination programs. Mexico integrated the rotavirus vaccine into its routine childhood immunisation schedule, making it widely accessible to infants as part of their regular vaccination regimen. According to the report, types are segmented into multivalent vaccines and monovalent vaccines. In Mexico, multivalent vaccines are the leading market. Multivalent vaccines combine protection against multiple diseases into a single vaccine, reducing the number of shots needed. This simplification is particularly advantageous for children who require numerous vaccinations in their early years, making it easier for parents and healthcare providers to adhere to the recommended vaccination schedule. Fewer injections increase the likelihood of individuals and parents complying with the recommended vaccination schedule. This results in higher vaccination rates and better public health outcomes. Combination vaccines are more efficient in terms of healthcare resources and logistics. They reduce the number of healthcare visits, the need for multiple syringes, and the storage space required for vaccines. Multivalent vaccines can be cost-effective for healthcare systems as they reduce the overall cost of vaccination programmes, including administration and distribution expenses. Distribution channel includes the Hospital Pharmacy, Retail Pharmacy, Institutional Sales and other. In Mexico the Institutional Sales is growing market, The Mexican government plays a significant role in public health initiatives, including vaccination programs. It often procures vaccines in bulk quantities to ensure that they are readily available for national immunization campaigns and routine vaccination schedules. Institutional sales channels ensure that vaccines are distributed to a wide range of healthcare facilities, including those in remote or underserved areas. This accessibility is crucial for reaching all segments of the population. Institutional sales channels ensure that vaccines are distributed to a wide range of healthcare facilities, including those in remote or underserved areas. This accessibility is crucial for reaching all segments of the population.

Considered in this report: • Geography: Mexico • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report: • Mexico Vaccines market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Technology • Conjugate vaccines • Inactivated & Subunit vaccines • Live Attenuated vaccines • Recombinant vaccines • Toxoid vaccines • Viral vector vaccines • Others By Route of Administration • Intramuscular and Subcutaneous Administration • Oral Administration • Others By Disease • Rotavirus • Pneumococcal diseases • Cancer • Influenza • Diphtheria, Pertussis, and Tetanus (DTP) • Human Papilloma Virus (HPV) • Hepatitis • Shingles • Meningococcal diseases • Varicella (Chicken Pox) • Mumps • Others By Type • Multivalent vaccines • Monovalent vaccines By End-User Type • Paediatrics • Adults By Distribution Channel • Hospital Pharmacy • Retail Pharmacy • Online Pharmacy • Others The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drone industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.